Clinical Research

Clinical Research Center

Dr. Tarpay also functions as a Certified Principal Investigator (ACRP) for the clinical research center. Clinical research trials are an important step in the development and approval of new medical treatments and devices or the improvement of those currently available.

What We Do

While the term may seem intimidating, Clinical Research gives volunteers access to the most state of the art treatment options available, as well as those not yet available. Our Research Center conducts both pre-market (pre-FDA approval) and post market trials which may study new drugs or new ways of administering drugs currently available. Some of our trials study the safety and/or the effectiveness of a particular treatment and others are head to head comparison of different treatment options.

Why Participate in a Clinical Trial?

When you choose to volunteer for clinical research programs, you are not only directly contributing to the advancement of medical care and treatment options, but you also give yourself or your child direct access to specialized medical care at no cost.

Therapeutic Areas We Cover

Our center offers several different clinical trials for both Adult and Pediatric patients. A few of the therapeutic areas covered include:

  • Asthma
  • COPD
  • Atopic Dermatitis
  • Seasonal Allergies
  • Perennial Allergies

If you are interested in taking part in one of our clinical research trials, or if you would like to learn more, please call 405.286.9431.

In the News

Dr. Tarpay featured on KFOR-TV

According to the Asthma and Allergy Foundation of America, Oklahoma City, OK, is one of the worst cities in the nation for allergies. Dr. Tarpay offers tips to keep pollen at bay:

View the video


PEANUT ALLERGY

The incidence of peanut allergy has significantly increased during the last 2 decades. A new study, the LEAP trial suggest that eating peanut early( during the first year of life ) may be associated with reduced risk of peanut allergy. Ten international medical organization created a " Consensus Communication "  an interim guidance for high risk infants. We expect new guidelines regarding feeding practices for healthy and high risk infants.  


Read More In The News Articles here >>